R&D Personnel and Expenditure
First written in FY2016. 3 of 36 entries say "Restated". Latest entry: FY2026.
90 other companies' latest entry also says "Other".
- FY2026Update to Full-Year Research and Development ResultsAnnual report
「The group had 13 development staff, representing 2.4% of all employees. Total R&D expenses for the fiscal year were ¥119 million. As of the end of the fiscal year, the group owned 77 industrial property rights.」
The company disclosed full-year results of 13 R&D staff, representing 2.4% of all employees, R&D expenses of ¥119 million, and 77 industrial property rights. - FY2026-H1Updated interim-period R&D resultsAnnual report
「The group's R&D expenses for the cumulative interim period were ¥62 million.」
The company disclosed cumulative interim-period R&D expenses of ¥62 million and stated that there had been no material change in its R&D activities. - FY2025Update to Full-Year Research and Development ResultsAnnual report
「The group had 13 development staff, representing 2.3% of all employees. Total R&D expenses for the fiscal year were ¥120 million. As of the end of the fiscal year, the group owned 84 industrial property rights.」
The company disclosed full-year results of 13 R&D staff, representing 2.3% of all employees, R&D expenses of ¥120 million, and 84 industrial property rights. - FY2025-H1Interim R&D Expense UpdateAnnual report
「The group's R&D expenses for the cumulative interim period were ¥58 million.」
The company disclosed cumulative interim-period R&D expenses of ¥58 million. - FY2024Update to Full-Year Research and Development ResultsAnnual report
「The group had 12 development staff, representing 2.1% of all employees. Total R&D expenses for the fiscal year were ¥138 million. As of the end of the fiscal year, the group owned 81 industrial property rights.」
The company disclosed 12 R&D staff, representing 2.1% of all employees, R&D expenses of ¥138 million, and 81 industrial property rights. These figures were up from 11 staff, 1.9%, R&D expenses of ¥108 million and 76 rights in the previous fiscal year. - FY2024-Q3Update to R&D expenses for the first 3 quartersAnnual report
「The group's R&D expenses for the cumulative third quarter were ¥78 million.」
The company disclosed cumulative third-quarter R&D expenses of ¥78 million and stated that there had been no material change in its R&D activities. - FY2024-Q2Second-quarter R&D expenses updatedAnnual report
「The group's R&D expenses for the cumulative second quarter were ¥63 million.」
The company disclosed cumulative second-quarter R&D expenses of ¥63 million. - FY2024-Q1First-quarter R&D expenses updatedAnnual report
「The group's R&D expenses for the cumulative first quarter were ¥34 million.」
The company disclosed cumulative first-quarter R&D expenses of ¥34 million and stated that there had been no material change in its R&D activities. - FY2023Update to Full-Year Research and Development ResultsAnnual report
「The group had 11 development staff, representing 1.9% of all employees. Total R&D expenses for the fiscal year were ¥108 million. As of the end of the fiscal year, the group owned 76 industrial property rights.」
The company disclosed 11 R&D staff, representing 1.9% of all employees, R&D expenses of ¥108 million, and 76 industrial property rights for the full fiscal year. - FY2023-Q3Update to R&D expenses for the first 3 quartersAnnual report
「The group's R&D expenses for the cumulative third quarter were ¥79 million.」
The company disclosed cumulative third-quarter R&D expenses of ¥79 million and stated that there had been no material change in its R&D activities. - FY2023-Q2Second-quarter R&D expenses updatedAnnual report
「The group's R&D expenses for the cumulative second quarter were ¥56 million.」
The company disclosed cumulative second-quarter R&D expenses of ¥56 million and stated that there had been no material change in its R&D activities. - FY2023-Q1First-quarter R&D expenses updatedAnnual report
「The group's R&D expenses for the cumulative first quarter were ¥23 million.」
The company disclosed cumulative first-quarter R&D expenses of ¥23 million and stated that there had been no material change in its R&D activities. - FY2022Update to Full-Year Research and Development ResultsAnnual report
「The group had 13 development staff, representing 2.2% of all employees. Total R&D expenses for the fiscal year were ¥107 million. As of the end of the fiscal year, the group owned 77 industrial property rights.」
The company disclosed full-year results of 13 R&D staff, representing 2.2% of all employees, R&D expenses of ¥107 million, and 77 industrial property rights. - FY2022-Q3Update to R&D expenses for the first 3 quartersAnnual report
「The group's R&D expenses for the cumulative third quarter were ¥73 million.」
The company disclosed cumulative third-quarter R&D expenses of ¥73 million and stated that there had been no material change in its R&D activities. - FY2022-Q2Second-quarter R&D expenses updatedAnnual report
「The group's R&D expenses for the cumulative second quarter were ¥52 million.」
The company disclosed cumulative second-quarter R&D expenses of ¥52 million and stated that there had been no material change in its R&D activities. - FY2022-Q1First-quarter R&D expenses updatedAnnual report
「The group's R&D expenses for the cumulative first quarter were ¥30 million.」
The company disclosed cumulative first-quarter R&D expenses of ¥30 million and stated that there had been no material change in its R&D activities. - FY2021-Q3Update to R&D expenses for the first 3 quartersAnnual report
「The group's R&D expenses for the cumulative third quarter were ¥92 million.」
The company disclosed cumulative third-quarter R&D expenses of ¥92 million and stated that there had been no material change in its R&D activities. - FY2021-Q2Second-quarter R&D expenses updatedAnnual report
「The group's R&D expenses for the cumulative second quarter were ¥53 million.」
The company disclosed cumulative second-quarter R&D expenses of ¥53 million and stated that there had been no material change in its R&D activities. - FY2021-Q1First-quarter R&D expenses updatedAnnual report
「The group's R&D expenses for the cumulative first quarter were ¥25 million.」
The company disclosed cumulative first-quarter R&D expenses of ¥25 million and stated that there had been no material change in its R&D activities. - FY2020Update to Full-Year ResultsAnnual report
「The group had 14 development staff, representing 2.2% of all employees. Total R&D expenses for the fiscal year were ¥132 million. As of the end of the fiscal year, the group owned 73 industrial property rights.」
The company disclosed 14 R&D staff, representing 2.2% of all employees, R&D expenses of ¥132 million, and 73 industrial property rights. - FY2020-Q3Update to R&D expenses for the first 3 quartersAnnual report
「The group's R&D expenses for the cumulative third quarter were ¥102 million.」
The company disclosed cumulative third-quarter R&D expenses of ¥102 million and stated that there had been no material change in its R&D activities. - FY2020-Q2Second-quarter R&D expenses updatedAnnual report
「The group's R&D expenses for the cumulative second quarter were ¥67 million.」
The company disclosed cumulative second-quarter R&D expenses of ¥67 million and stated that there had been no material change in its R&D activities. - FY2020-Q1First-quarter R&D expenses updatedAnnual report
「The group's R&D expenses for the cumulative first quarter were ¥34 million.」
The company disclosed cumulative first-quarter R&D expenses of ¥34 million and stated that there had been no material change in its R&D activities. - FY2019Update to Full-Year ResultsAnnual report
「The group had 15 development staff, representing 2.3% of all employees. Total R&D expenses for the fiscal year were ¥134 million. As of the end of the fiscal year, the group owned 72 industrial property rights.」
The company disclosed 15 R&D staff, representing 2.3% of all employees, R&D expenses of ¥134 million, and 72 industrial property rights. R&D expenses were down from ¥149 million in the previous fiscal year. - FY2019-Q3Update to R&D expenses for the first 3 quartersAnnual report
「The group's R&D expenses for the cumulative third quarter were ¥100 million.」
The company disclosed cumulative third-quarter R&D expenses of ¥100 million and stated that there had been no material change in its R&D activities. - FY2019-Q2Second-quarter R&D expenses updatedAnnual report
「The group's R&D expenses for the cumulative second quarter were ¥77 million.」
The company disclosed cumulative second-quarter R&D expenses of ¥77 million and stated that there had been no material change in its R&D activities. - FY2019-Q1First-quarter R&D expenses updatedAnnual report
「The group's R&D expenses for the cumulative first quarter were ¥35 million.」
The company disclosed first-quarter R&D expenses of ¥35 million and stated that there had been no material change in its R&D activities. - FY2018Update to Full-Year ResultsAnnual report
「The group had 15 development staff, representing 2.3% of all employees. Total R&D expenses for the fiscal year were ¥149 million.」
The company disclosed 15 R&D staff, representing 2.3% of all employees, and R&D expenses of ¥149 million. These figures were down from 17 staff, 2.6% and ¥156 million, respectively, in the previous fiscal year. - FY2018-Q3Added third-quarter resultsAnnual report
「The group's R&D expenses for the cumulative third quarter were ¥108 million. There was no material change in the status of the group's R&D activities during the cumulative third quarter.」
The company disclosed cumulative third-quarter R&D expenses of ¥108 million and stated that there had been no material change in its R&D activities. - FY2018-Q2Added second-quarter resultsAnnual report
「The group's R&D expenses for the cumulative second quarter were ¥73 million. There was no material change in the status of the group's R&D activities during the cumulative second quarter.」
The company disclosed cumulative second-quarter R&D expenses of ¥73 million and stated that there had been no material change in its R&D activities. - FY2018-Q1Added first-quarter resultsAnnual report
「The group's R&D expenses for the cumulative first quarter were ¥37 million.」
The company disclosed first-quarter R&D expenses of ¥37 million and stated that there had been no material change in its R&D activities. - FY2017Addition of full-year resultsAnnual report
「The group had 17 development staff, representing 2.6% of all employees. Total R&D expenses for the fiscal year were ¥156 million.」
The company disclosed 17 R&D staff, representing 2.6% of all employees, and R&D expenses of ¥156 million for the full fiscal year. - FY2017-Q3RestatedAnnual report
「The amount spent on research and development activities across the Group during the first nine months of the current consolidated cumulative period was ¥118 million. There were no material changes in the status of the Group's research and development activities during the first nine months of the current consolidated cumulative period.」
The Company disclosed research and development expenses of ¥118 million and stated that there had been no material changes in the status of its research and development activities. - FY2017-Q2RestatedAnnual report
「The amount spent on research and development activities across the Group during the first half of the current consolidated cumulative period was ¥80 million. There were no material changes in the status of the Group's research and development activities during the first half of the current consolidated cumulative period.」
The Company disclosed first-half research and development expenses of ¥80 million and stated that there had been no material changes in the status of its research and development activities. - FY2017-Q1RestatedAnnual report
「The amount spent on research and development activities across the Group during the first quarter of the current consolidated cumulative period was ¥36 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated cumulative period.」
The Company disclosed quarterly research and development expenses of ¥36 million and stated that there had been no material changes in the status of its research and development activities. - FY2016First statedAnnual report
「The Group currently has 16 development staff members, representing 2.4% of all employees. Total research and development expenses for the consolidated fiscal year were ¥155 million.」
The Company disclosed 16 research and development staff members, representing 2.4% of all employees, and research and development expenses of ¥155 million.